Alliancebernstein L.P. Lexicon Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

$275 Billion
Q1 2024

A detailed history of Alliancebernstein L.P. transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 219,941 shares of LXRX stock, worth $351,905. This represents 0.0% of its overall portfolio holdings.

Number of Shares

219,941

Previous 245,301 10.34%

Holding current value

$351,905

Previous $375,000 40.53%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$1.3 - $3.58 $32,968 - $90,788	-25,360 Reduced 10.34%	219,941 $527,000
Q3 2023 Nov 14, 2023	BUY	$1.06 - $2.33 $19,281 - $42,382	18,190 Added 8.01%	245,301 $267,000
Q2 2023 Aug 15, 2023	BUY	$2.15 - $3.49 $287,455 - $466,613	133,700 Added 143.13%	227,111 $520,000
Q1 2023 May 15, 2023	BUY	$1.99 - $2.68 $7,164 - $9,648	3,600 Added 4.01%	93,411 $226,000
Q4 2022 Feb 14, 2023	BUY	$1.8 - $2.56 $8,640 - $12,288	4,800 Added 5.65%	89,811 $171,000

Q3 2022 Nov 15, 2022	BUY	$1.94 - $3.43 $55,096 - $97,412	28,400 Added 50.17%	85,011 $204,000
Q2 2022 Aug 15, 2022	BUY	$1.31 - $2.69 $8,122 - $16,678	6,200 Added 12.3%	56,611 $105,000
Q1 2022 May 13, 2022	BUY	$1.95 - $3.89 $585 - $1,167	300 Added 0.6%	50,411 $105,000
Q3 2021 Nov 10, 2021	SELL	$3.38 - $5.35 $20,280 - $32,099	-6,000 Reduced 10.69%	50,111 $241,000
Q2 2021 Jul 30, 2021	BUY	$4.12 - $5.87 $49,440 - $70,440	12,000 Added 27.2%	56,111 $258,000
Q1 2021 May 06, 2021	SELL	$3.45 - $9.09 $50,025 - $131,805	-14,500 Reduced 24.74%	44,111 $259,000
Q4 2020 Feb 08, 2021	SELL	$1.05 - $3.67 $54,014 - $188,792	-51,442 Reduced 46.74%	58,611 $200,000
Q3 2020 Nov 12, 2020	SELL	$1.44 - $2.1 $103,248 - $150,570	-71,700 Reduced 39.45%	110,053 $158,000
Q2 2020 Aug 13, 2020	BUY	$1.75 - $2.3 $69,912 - $91,885	39,950 Added 28.17%	181,753 $363,000
Q1 2020 May 14, 2020	BUY	$1.8 - $4.28 $77,940 - $185,324	43,300 Added 43.96%	141,803 $277,000
Q2 2019 Aug 14, 2019	BUY	$5.35 - $7.11 $97,370 - $129,402	18,200 Added 22.66%	98,503 $620,000
Q1 2019 May 14, 2019	SELL	$4.36 - $7.94 $39,240 - $71,460	-9,000 Reduced 10.08%	80,303 $446,000
Q4 2018 Feb 13, 2019	BUY	$6.15 - $10.51 $37,515 - $64,111	6,100 Added 7.33%	89,303 $593,000
Q3 2018 Nov 08, 2018	SELL	$10.32 - $13.06 $1,847 - $2,337	-179 Reduced 0.21%	83,203 $888,000
Q2 2018 Aug 13, 2018	BUY	$7.8 - $13.69 $69,420 - $121,841	8,900 Added 11.95%	83,382 $1 Million
Q4 2017 Feb 13, 2018	SELL	$8.77 - $12.28 $941,021 - $1.32 Million	-107,300 Reduced 59.03%	74,482 $736,000
Q3 2017 Nov 13, 2017	BUY	$12.17 - $16.3 $2.21 Million - $2.96 Million	181,782	181,782 $2.23 Million

Others Institutions Holding LXRX

# of Institutions

122

Shares Held

159M

Call Options Held

2.11M

Put Options Held

412K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $302M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Lexicon Pharmaceuticals, Inc. Transaction History